NeuroTrax Corp

NeuroTrax Corp is a leading provider of medical-grade cognitive health assessment software serving clinical, research, and legal markets. The company has delivered evidence-based cognitive testing platforms for over 20 years to major institutions, hospitals, and research facilities. NeuroTrax specializes in objective measurement of cognitive function across seven major cognitive domains: attention, executive function, information processing, verbal function, attention span, visuospatial skills, and motor skills. The platform enables early detection of cognitive impairment through digital, adaptive testing administered in under one hour in clinical offices or research facilities. Clinical users benefit from CPT code reimbursability (96132, 96133, 96136, 96137, 96138, 96139, 96146) and longitudinal tracking capabilities to monitor disease progression and treatment effects. Researchers access data exports in statistics-ready formats compatible with major analysis tools and research workflows. The platform has been validated in hundreds of peer-reviewed publications in leading medical journals. NeuroTrax serves neurologists, neuropsychologists, primary care physicians, clinical specialists, researchers, and legal professionals requiring objective cognitive performance measurement. The system generates detailed, patient-friendly reports supporting clinician-directed care planning and research analysis. Administration requires only a quiet room and computer, with no specialized equipment necessary.